Literature DB >> 16782872

Essential role of Vav family guanine nucleotide exchange factors in EphA receptor-mediated angiogenesis.

Sonja G Hunter1, Guanglei Zhuang, Dana Brantley-Sieders, Wojciech Swat, Christopher W Cowan, Jin Chen.   

Abstract

Angiogenesis, the process by which new blood vessels are formed from preexisting vasculature, is critical for vascular remodeling during development and contributes to the pathogenesis of diseases such as cancer. Prior studies from our laboratory demonstrate that the EphA2 receptor tyrosine kinase is a key regulator of angiogenesis in vivo. The EphA receptor-mediated angiogenic response is dependent on activation of Rho family GTPase Rac1 and is regulated by phosphatidylinositol 3-kinase. Here we report the identification of Vav2 and Vav3 as guanine nucleotide exchange factors (GEFs) that link the EphA2 receptor to Rho family GTPase activation and angiogenesis. Ephrin-A1 stimulation recruits the binding of Vav proteins to the activated EphA2 receptor. The induced association of EphA receptor and Vav proteins modulates the activity of Vav GEFs, leading to activation of Rac1 GTPase. Overexpression of either Vav2 or Vav3 in primary microvascular endothelial cells promotes Rac1 activation, cell migration, and assembly in response to ephrin-A1 stimulation. Conversely, loss of Vav2 and Vav3 GEFs inhibits Rac1 activation and ephrin-A1-induced angiogenic responses both in vitro and in vivo. In addition, embryonic fibroblasts derived from Vav2-/- Vav3-/- mice fail to spread on an ephrin-A1-coated surface and exhibit a significant decrease in the formation of ephrin-A1-induced lamellipodia and filopodia. These findings suggest that Vav GEFs serve as a molecular link between EphA2 receptors and the actin cytoskeleton and provide an important mechanism for EphA2-mediated angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16782872      PMCID: PMC1489141          DOI: 10.1128/MCB.02215-05

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  50 in total

1.  Control of intramolecular interactions between the pleckstrin homology and Dbl homology domains of Vav and Sos1 regulates Rac binding.

Authors:  B Das; X Shu; G J Day; J Han; U M Krishna; J R Falck; D Broek
Journal:  J Biol Chem       Date:  2000-05-19       Impact factor: 5.157

2.  Vav2 is an activator of Cdc42, Rac1, and RhoA.

Authors:  K Abe; K L Rossman; B Liu; K D Ritola; D Chiang; S L Campbell; K Burridge; C J Der
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

3.  Major transcript variants of VAV3, a new member of the VAV family of guanine nucleotide exchange factors.

Authors:  T Trenkle; M McClelland; K Adlkofer; J Welsh
Journal:  Gene       Date:  2000-03-07       Impact factor: 3.688

4.  Replacing two conserved tyrosines of the EphB2 receptor with glutamic acid prevents binding of SH2 domains without abrogating kinase activity and biological responses.

Authors:  A H Zisch; C Pazzagli; A L Freeman; M Schneller; M Hadman; J W Smith; E Ruoslahti; E B Pasquale
Journal:  Oncogene       Date:  2000-01-13       Impact factor: 9.867

Review 5.  Vascular-specific growth factors and blood vessel formation.

Authors:  G D Yancopoulos; S Davis; N W Gale; J S Rudge; S J Wiegand; J Holash
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

6.  Vav family proteins couple to diverse cell surface receptors.

Authors:  S L Moores; L M Selfors; J Fredericks; T Breit; K Fujikawa; F W Alt; J S Brugge; W Swat
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

7.  Vav3 mediates receptor protein tyrosine kinase signaling, regulates GTPase activity, modulates cell morphology, and induces cell transformation.

Authors:  L Zeng; P Sachdev; L Yan; J L Chan; T Trenkle; M McClelland; J Welsh; L H Wang
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

8.  Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization.

Authors:  A Pozzi; P E Moberg; L A Miles; S Wagner; P Soloway; H A Gardner
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

9.  Phosphorylation of tyrosine residues in the kinase domain and juxtamembrane region regulates the biological and catalytic activities of Eph receptors.

Authors:  K L Binns; P P Taylor; F Sicheri; T Pawson; S J Holland
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

10.  Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4.

Authors:  H U Wang; Z F Chen; D J Anderson
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

View more
  63 in total

Review 1.  The role of endocytosis in activating and regulating signal transduction.

Authors:  Emma R Andersson
Journal:  Cell Mol Life Sci       Date:  2011-11-24       Impact factor: 9.261

Review 2.  Axon guidance molecules in vascular patterning.

Authors:  Ralf H Adams; Anne Eichmann
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-03-31       Impact factor: 10.005

3.  Astrocyte-produced ephrins inhibit schwann cell migration via VAV2 signaling.

Authors:  Fardad T Afshari; Jessica C Kwok; James W Fawcett
Journal:  J Neurosci       Date:  2010-03-24       Impact factor: 6.167

Review 4.  Eph receptors and ephrins in cancer: bidirectional signalling and beyond.

Authors:  Elena B Pasquale
Journal:  Nat Rev Cancer       Date:  2010-03       Impact factor: 60.716

Review 5.  Bidirectional ephrin/Eph signaling in synaptic functions.

Authors:  Jason Aoto; Lu Chen
Journal:  Brain Res       Date:  2006-12-12       Impact factor: 3.252

6.  Identification of phosphotyrosine binding domain-containing proteins as novel downstream targets of the EphA8 signaling function.

Authors:  Jongdae Shin; Changkyu Gu; Eunjeong Park; Soochul Park
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

7.  Small molecules can selectively inhibit ephrin binding to the EphA4 and EphA2 receptors.

Authors:  Roberta Noberini; Mitchell Koolpe; Satyamaheshwar Peddibhotla; Russell Dahl; Ying Su; Nicholas D P Cosford; Gregory P Roth; Elena B Pasquale
Journal:  J Biol Chem       Date:  2008-08-26       Impact factor: 5.157

Review 8.  The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting.

Authors:  Jill Wykosky; Waldemar Debinski
Journal:  Mol Cancer Res       Date:  2008-12       Impact factor: 5.852

9.  Function of the nucleotide exchange activity of vav1 in T cell development and activation.

Authors:  Alexander Saveliev; Lesley Vanes; Olga Ksionda; Jonathan Rapley; Stephen J Smerdon; Katrin Rittinger; Victor L J Tybulewicz
Journal:  Sci Signal       Date:  2009-12-15       Impact factor: 8.192

10.  Identification and functional analysis of phosphorylated tyrosine residues within EphA2 receptor tyrosine kinase.

Authors:  Wei Bin Fang; Dana M Brantley-Sieders; Yoonha Hwang; Amy-Joan L Ham; Jin Chen
Journal:  J Biol Chem       Date:  2008-04-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.